The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis.
Saved in:
| Title: | The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis. |
|---|---|
| Authors: | Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Porta FM; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Olmeda E; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Gaeta A; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Boscolo Bielo L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Conversano F; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., De Pas TM; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo 24125, Italy., Castellano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Santoro C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Battaiotto E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy., Mane E; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Coppola S; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan 20141, Italy., Conforti F; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo 24125, Italy., Mattar D; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan 20141, Italy., Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Veronesi P; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan 20141, Italy., Guerini Rocco E; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy., Pennacchioli E; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan 20141, Italy., Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy. |
| Source: | The oncologist [Oncologist] 2025 Feb 06; Vol. 30 (2). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39921370 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Valenza+C%22">Valenza C</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.<br /><searchLink fieldCode="AU" term="%22Trapani+D%22">Trapani D</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.<br /><searchLink fieldCode="AU" term="%22Porta+FM%22">Porta FM</searchLink>; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Olmeda+E%22">Olmeda E</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Gaeta+A%22">Gaeta A</searchLink>; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Boscolo+Bielo+L%22">Boscolo Bielo L</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.<br /><searchLink fieldCode="AU" term="%22Conversano+F%22">Conversano F</searchLink>; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22De+Pas+TM%22">De Pas TM</searchLink>; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo 24125, Italy.<br /><searchLink fieldCode="AU" term="%22Castellano+G%22">Castellano G</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.<br /><searchLink fieldCode="AU" term="%22Santoro+C%22">Santoro C</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.<br /><searchLink fieldCode="AU" term="%22Battaiotto+E%22">Battaiotto E</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.<br /><searchLink fieldCode="AU" term="%22Mane+E%22">Mane E</searchLink>; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Coppola+S%22">Coppola S</searchLink>; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Conforti+F%22">Conforti F</searchLink>; Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo 24125, Italy.<br /><searchLink fieldCode="AU" term="%22Mattar+D%22">Mattar D</searchLink>; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Gandini+S%22">Gandini S</searchLink>; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Veronesi+P%22">Veronesi P</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Guerini+Rocco+E%22">Guerini Rocco E</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.; Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Pennacchioli+E%22">Pennacchioli E</searchLink>; Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan 20141, Italy.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2025 Feb 06; Vol. 30 (2). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39921370 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/oncolo/oyaf012 Languages: – Code: eng Text: English Titles: – TitleFull: The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Valenza C – PersonEntity: Name: NameFull: Trapani D – PersonEntity: Name: NameFull: Porta FM – PersonEntity: Name: NameFull: Olmeda E – PersonEntity: Name: NameFull: Gaeta A – PersonEntity: Name: NameFull: Boscolo Bielo L – PersonEntity: Name: NameFull: Conversano F – PersonEntity: Name: NameFull: De Pas TM – PersonEntity: Name: NameFull: Castellano G – PersonEntity: Name: NameFull: Santoro C – PersonEntity: Name: NameFull: Battaiotto E – PersonEntity: Name: NameFull: Mane E – PersonEntity: Name: NameFull: Coppola S – PersonEntity: Name: NameFull: Conforti F – PersonEntity: Name: NameFull: Mattar D – PersonEntity: Name: NameFull: Gandini S – PersonEntity: Name: NameFull: Veronesi P – PersonEntity: Name: NameFull: Guerini Rocco E – PersonEntity: Name: NameFull: Pennacchioli E – PersonEntity: Name: NameFull: Curigliano G IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 02 Text: 2025 Feb 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1549-490X Numbering: – Type: volume Value: 30 – Type: issue Value: 2 Titles: – TitleFull: The oncologist Type: main |
| ResultId | 1 |
